Clinical study on meropenem in the treatment of bacterial infection

Objective To evaluate the efficacy and safety of domestic meropenem (Beineng) injection in treatment of severe bactenal infection. Methods A randomized controlled clinical trial was conducted,while the imported meropenem (Mepem) was used as the control. Results The overall efficacy rates of Beineng and Mepem were 81.60% and 82.39%,respectively. The bacterial clearance rates were 88.64% and 91.10%,respectively. The incidence rates of adverse reaction were 5.52% and 5.11%,respectively. There was no significant difference between the two groups for the above results. Conclusions Domestic meropenem (Beineng) injection is an antibacterial agent for bacterial infection with high efficacy and safety.